批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2024/10/18 |
ORIG-1(原始申请) |
Approval |
|
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
无 |
与本品治疗等效的药品
活性成分:MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE 剂型/给药途径:SOLUTION;ORAL 规格:1.6GM/BOT;3.13GM/BOT;17.5GM/BOT 治疗等效代码:AA
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022372 |
001 |
NDA |
SUPREP BOWEL PREP KIT |
MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE |
SOLUTION;ORAL |
1.6GM/BOT;3.13GM/BOT;17.5GM/BOT |
Prescription |
Yes |
Yes |
AA |
2010/08/05
|
BRAINTREE LABS |
202511 |
001 |
ANDA |
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE |
MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE |
SOLUTION;ORAL |
1.6GM/BOT;3.13GM/BOT;17.5GM/BOT |
Prescription |
No |
No |
AA |
2017/02/23
|
NOVEL LABS INC |
215469 |
001 |
ANDA |
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE |
MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE |
SOLUTION;ORAL |
1.6GM/BOT;3.13GM/BOT;17.5GM/BOT |
Prescription |
No |
No |
AA |
2023/11/22
|
STRIDES PHARMA |
213924 |
001 |
ANDA |
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE |
MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE |
SOLUTION;ORAL |
1.6GM/BOT;3.13GM/BOT;17.5GM/BOT |
Prescription |
No |
No |
AA |
2023/12/29
|
ALKEM LABS LTD |
206431 |
001 |
ANDA |
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE |
MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE |
SOLUTION;ORAL |
1.6GM/BOT;3.13GM/BOT;17.5GM/BOT |
Prescription |
No |
No |
AA |
2024/03/19
|
TARO |
204135 |
001 |
ANDA |
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE |
MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE |
SOLUTION;ORAL |
1.6GM/BOT;3.13GM/BOT;17.5GM/BOT |
Prescription |
No |
No |
AA |
2024/06/24
|
BIONPHARMA |
209941 |
001 |
ANDA |
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE |
MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE |
SOLUTION;ORAL |
1.6GM/BOT;3.13GM/BOT;17.5GM/BOT |
Prescription |
No |
No |
AA |
2024/07/15
|
PAI HOLDINGS |
212903 |
001 |
ANDA |
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE |
MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE |
SOLUTION;ORAL |
1.6GM/BOT;3.13GM/BOT;17.5GM/BOT |
Prescription |
No |
No |
AA |
2024/10/18
|
ANNORA PHARMA |